Gender-Specific Differences in Diastolic Dysfunction and HFpEF: Pathophysiology, Diagnosis, and Therapeutic Strategies.

J Cardiovasc Dev Dis · 2025 · PMC12194537 · PMID 40558648

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the EMPEROR-PRESERVED trial, women experienced a 25% relative risk reduction in the primary outcome compared to 19% in men, although this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.